Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3)
Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers. - page 3, paragraph 3 under the 'Interventions' sec...
Autores Principales: | , , , , , , , , |
---|---|
Formato: | Otro (Other) |
Lenguaje: | Inglés (English) |
Publicado: |
BioMed Central Ltd.
2019
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/23395 https://doi.org/10.1186/s13063-019-3630-y |
id |
ir-10336-23395 |
---|---|
recordtype |
dspace |
spelling |
ir-10336-233952022-05-02T12:37:15Z Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) Villar, Juan Carlos Herrera, Víctor Mauricio Carreño, Juan Guillermo Pérez Herrera, Eliana Váquiro Domínguez, Yeny Zulay Castellanos Vásquez, Skarlet Marcell Cucunubá, Zulma Milena Prado, Nilda Graciela Hernández, Yolanda Erratum Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers. - page 3, paragraph 3 under the 'Interventions' section, the reference to Table 1 was deleted from the text - page 4, first paragraph under the 'Comparisons' section, BZN was replaced with BZN/60CD and NFX was replaced with NFX/120HD - page 5, the reference to Figure 2 was replaced with Table 2 within the text - page 6, first paragraph, 1st line, under the 'Laboratory testing' section, 'Outcome date' should read 'Efficacy outcome data' and 'the outcome when they are processed' on the 6th line should read 'the efficacy outcome when they are processed'. - page 7: - - the reference to Table 2 was replaced with Table 3 - - first paragraph, 4th line, under the 'Randomisation' section, the text 'of similar aspect, whose content is unknown' was deleted - - first paragraph, 4th line, under the 'Discussion' section, 'Most of these trials with relatively little data' should read 'Most with relatively little data' - In both figures of the manuscript, referring to the study drugs, the short forms used for Benznidazole (BZD) were different from what is used throughout the manuscript (BZN). The BZN for is kept. - The figure and table captions have been corrected: igure 2 - Incorrect caption: Process of treatment allocation - Corrected caption: Daily 60-day treatment schedule for study participants. © 2019 The Author(s). 2019 2020-05-26T00:01:41Z info:eu-repo/semantics/other info:eu-repo/semantics/publishedVersion 17456215 https://repository.urosario.edu.co/handle/10336/23395 https://doi.org/10.1186/s13063-019-3630-y eng info:eu-repo/semantics/openAccess application/pdf BioMed Central Ltd. instname:Universidad del Rosario |
institution |
EdocUR - Universidad del Rosario |
collection |
DSpace |
language |
Inglés (English) |
topic |
Erratum |
spellingShingle |
Erratum Villar, Juan Carlos Herrera, Víctor Mauricio Carreño, Juan Guillermo Pérez Herrera, Eliana Váquiro Domínguez, Yeny Zulay Castellanos Vásquez, Skarlet Marcell Cucunubá, Zulma Milena Prado, Nilda Graciela Hernández, Yolanda Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
description |
Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers. - page 3, paragraph 3 under the 'Interventions' section, the reference to Table 1 was deleted from the text - page 4, first paragraph under the 'Comparisons' section, BZN was replaced with BZN/60CD and NFX was replaced with NFX/120HD - page 5, the reference to Figure 2 was replaced with Table 2 within the text - page 6, first paragraph, 1st line, under the 'Laboratory testing' section, 'Outcome date' should read 'Efficacy outcome data' and 'the outcome when they are processed' on the 6th line should read 'the efficacy outcome when they are processed'. - page 7: - - the reference to Table 2 was replaced with Table 3 - - first paragraph, 4th line, under the 'Randomisation' section, the text 'of similar aspect, whose content is unknown' was deleted - - first paragraph, 4th line, under the 'Discussion' section, 'Most of these trials with relatively little data' should read 'Most with relatively little data' - In both figures of the manuscript, referring to the study drugs, the short forms used for Benznidazole (BZD) were different from what is used throughout the manuscript (BZN). The BZN for is kept. - The figure and table captions have been corrected: igure 2 - Incorrect caption: Process of treatment allocation - Corrected caption: Daily 60-day treatment schedule for study participants. © 2019 The Author(s). |
format |
Otro (Other) |
author |
Villar, Juan Carlos Herrera, Víctor Mauricio Carreño, Juan Guillermo Pérez Herrera, Eliana Váquiro Domínguez, Yeny Zulay Castellanos Vásquez, Skarlet Marcell Cucunubá, Zulma Milena Prado, Nilda Graciela Hernández, Yolanda |
author_facet |
Villar, Juan Carlos Herrera, Víctor Mauricio Carreño, Juan Guillermo Pérez Herrera, Eliana Váquiro Domínguez, Yeny Zulay Castellanos Vásquez, Skarlet Marcell Cucunubá, Zulma Milena Prado, Nilda Graciela Hernández, Yolanda |
author_sort |
Villar, Juan Carlos |
title |
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
title_short |
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
title_full |
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
title_fullStr |
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
title_full_unstemmed |
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3) |
title_sort |
correction to: nifurtimox versus benznidazole or placebo for asymptomatic trypanosoma cruzi infection (equivalence of usual interventions for trypanosomiasis - equity): study protocol for a randomised controlled trial (trials doi: 10.1186/s13063-019-3423-3) |
publisher |
BioMed Central Ltd. |
publishDate |
2019 |
url |
https://repository.urosario.edu.co/handle/10336/23395 https://doi.org/10.1186/s13063-019-3630-y |
_version_ |
1740172382956421120 |
score |
12,131701 |